Partners smiling at each other in doctors office

Who it’s for

Meet the
TriNav® Patient

Getting more therapy to the tumor and preserving healthy tissue is particularly important in complex liver cancer patients with higher disease burden.

Talk to a Representative
Explore Resources

patient types

Patients Who May Benefit From TriNav

Prior Embolization

Large Tumors

Multi-Focal Disease

Borderline Liver Function

Hypovascular Tumors

Previous tumor presence can complicate treatment

Previously embolized tumors can be more difficult to visualize and penetrate due to regions of necrosis and damaged vasculature.1

Scan showing prior embolization

Tumor size can affect therapy efficacy

Lack of particle penetration may be the cause of poor response to embolization in patients with large (>5 cm) tumors.2

Scan showing a large liver tumor

Multiple tumors can cause additional challenges

It can be difficult to deliver adequate treatment while minimizing injury to normal liver in patients with multiple tumors.3

Scan showing multi focal disease

Protecting the liver is critical

In patients with borderline liver function, the approach must achieve a two-fold goal of effective treatment while preserving adequate healthy liver tissue.4 Elevated liver biomarkers are associated with poor prognosis in HCC.5

Scan showing borderline liver function

Reduced vascularity limit pathways to penetration

It can be challenging to achieve adequate particle penetration into tumors with minimal or absent enhancement due to reduced vascularity.6

Scan showing hypovascular tumor

    Why It Matters / How Patients Can Benefit

    It’s about quality of life

    In a comprehensive Real-World Evidence study, patients treated with SmartValve Technology experienced fewer in-patient visits and complications post-procedure.7,8

    21% reduced 

    instance of fatigue (20.9% vs. 26.4%)7,8

    61% reduced

    incidence of gastric ulcers (1.8% vs. 4.7%)7,8

    49% reduced

    reports of jaundice (3.7% vs. 7.3%)7,8

    Learn more about TriNav’s reimbursement and economic value.

    Learn More